Clinical Trial Update: Stress, Inflammation and Immune Response Pilot Study- Aim 3 [EARLY_Phase 1]

View source ↗

Summary

This early-phase Phase 1 pilot trial investigates how stress, inflammation, and immune response interact in systemic lupus erythematosus, and reports completion…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Lupus Erythematosus

Snippet

Sponsor: University of Wisconsin, Madison | Conditions: Systemic Lupus Erythematosus, Inflammation | EARLY_Phase 1 | Status: COMPLETED